Paola Begini

Rome, 00189, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study.

Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study.

Journal: Viruses
Published: August 02, 2024

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.

Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.

Journal: JHEP reports : innovation in hepatology
Published: July 30, 2024

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study.

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study.

Journal: Cancers
Published: May 21, 2021

Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features.

Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features.

Journal: Diagnostics (Basel, Switzerland)
Published: April 30, 2021

COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study.

COVID-19 emergency: Changes in quality of life perception in patients with chronic liver disease-An Italian single-centre study.

Journal: World journal of hepatology
Published: March 17, 2021

Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy.

Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy.

Journal: Microorganisms
Published: September 23, 2020

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study.

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study.

Journal: Drugs in context
Published: April 04, 2020

Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management.

Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management.

Journal: Viruses
Published: July 23, 2019

Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment.

Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment.

Journal: United European gastroenterology journal
Published: April 14, 2018

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Journal: Annals of hepatology
Published: April 03, 2018

Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines.

Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines.

Journal: Oncotarget
Published: February 12, 2018

Hepatitis B in patients with hematological diseases: An update.

Hepatitis B in patients with hematological diseases: An update.

Journal: World journal of hepatology
Published: May 27, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026